[Helicobacter pylori and atherosclerosis. A review of the literature]
Related Experiment Video
Updated: Jun 24, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Francesco Franceschi1, Eliano Pio Navarese, Roberto Mollo
1Istituto di Medicina Interna, Università Cattolica del Sacro Cuore, Roma. francesco.franceschi@rm.unicatt.it
Abstract:
Several studies have investigated potential role of Helicobacter pylori (Hp) in the pathogenesis of atherosclerosis. Postulated mechanisms are various, even though results are still controversial. Here we propose an overview of actual knowledge about this topic, comparing studies in favour with those against the relationship between Hp and atherosclerosis.
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
